Vectus Biosystems (ASX:VBS) Common Stock: A$38.37 Mil (As of Dec. 2025)


ASX:VBS Vectus Biosystems Ltd ASX:VBS
18 GF Score
Price A$0.12
! 2 Warning Signs
View Full Analysis

What is Vectus Biosystems Common Stock?

Vectus Biosystems ASX:VBS -11.54% 18 Common Stock is A$38.37 Mil as of Dec. 2025. GuruFocus rates ASX:VBS with a GF Score™ of 18/100. The stock has 2 warning signs investors should review.

Vectus Biosystems's quarterly common stock stayed the same from Dec. 2024 (A$38.37 Mil) to Jun. 2025 (A$38.37 Mil) and stayed the same from Jun. 2025 (A$38.37 Mil) to Dec. 2025 (A$38.37 Mil).

Vectus Biosystems's annual common stock increased from Jun. 2023 (A$38.35 Mil) to Jun. 2024 (A$38.37 Mil) but then stayed the same from Jun. 2024 (A$38.37 Mil) to Jun. 2025 (A$38.37 Mil).

Vectus Biosystems Common Stock Historical Data

* Premium members only.

The historical data trend for Vectus Biosystems's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vectus Biosystems Common Stock Chart

Vectus Biosystems Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Common Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only 24.84 27.30 38.35 38.37 38.37

Vectus Biosystems Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 38.37 38.37 38.37 38.37 38.37
ASX:VBS
18GF Score
Vectus Biosystems Ltd ASX:VBS
Common Stock is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Vectus Biosystems Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of A$38.37 Mil mean?
Vectus Biosystems (ASX:VBS) has a Common Stock of A$38.37 Mil as of Dec. 2025. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Vectus Biosystems and its competitors.
Is Vectus Biosystems' Common Stock too high?
Vectus Biosystems' current Common Stock is A$38.37 Mil. Overall, Vectus Biosystems has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Vectus Biosystems' Common Stock compare to VRTX and REGN?
Vectus Biosystems' Common Stock of A$38.37 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Biotechnology company?
A good Common Stock depends on the Biotechnology industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Vectus Biosystems and its competitors. Vectus Biosystems's current Common Stock is A$38.37 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vectus Biosystems stock overvalued right now?
Vectus Biosystems (ASX:VBS) has a current Common Stock of A$38.37 Mil. The current Common Stock is A$38.37 Mil. Vectus Biosystems' overall GF Score™ is 18/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For Vectus Biosystems (ASX:VBS), the current Common Stock is A$38.37 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Vectus Biosystems Business Description

Address 26-34 Dunning Avenue, Unit 5, Ground Floor, Rosebery, Sydney, NSW, AUS, 2018
Vectus Biosystems Ltd is an emerging biotechnology company based in Sydney, Australia. The company has developed and patented various novel compounds for the treatment of chronic fibrosis, including heart, kidney, liver, and lung fibrosis. Its drug candidate VB0004, is aimed at inhibiting and reversing the loss of functional tissue due to fibrosis, is in its human trials phase.
18GF Score

Get the complete analysis for ASX:VBS

Common Stock is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$0.12
Price